The cyclic AMP effects and neuroprotective activities of PACAP and VIP in cultured astrocytes and neurons exposed to oxygen-glucose deprivation

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pharmacological Reports

• Publication date

  2015-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.pharep.2014.10.001PMID 25712659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Effects of CoCl2 on HIF-1α Protein under Experimental Conditions of Autoprogressive Hypoxia Using Mouse Models

  2014cited by this paper
• Immunosuppressant FK506: focusing on neuroprotective effects following brain and spinal cord injury.

  2012cited by this paper
• New approaches to neuroprotective drug development.

  2011cited by this paper
• FK506 ameliorates oxidative damage and protects rat brain following transient focal cerebral ischemia

  2011cited by this paper
• PACAP and a novel stable analog protect rat brain from ischemia: Insight into the mechanisms of action.

  2011cited by this paper
• Endogenous pituitary adenylate cyclase activating polypeptide is involved in suppression of edema in the ischemic brain.

  2010cited by this paper
• Neuroprotective Effect of PACAP on Translational Control Alteration and Cognitive Decline in MPTP Parkinsonian Mice

  2010cited by this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery

  2009cited by this paper
• Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review.

  2009cited by this paper
• Astrocytes and Ischemic Injury

  2009cited by this paper
• Poststroke treatment: lost in translation.

  2009cited by this paper
• Role of PACAP in Ischemic Neural Death

  2008cited by this paper
• Guidelines for management of ischaemic stroke and transient ischaemic attack 2008.

  2008cited by this paper
• Inhibitory Effect of PACAP on Caspase Activity in Neuronal Apoptosis: A Better Understanding Towards Therapeutic Applications in Neurodegenerative Diseases

  2008cited by this paper
• Effects of PACAP, VIP and related peptides on cyclic AMP formation in rat neuronal and astrocyte cultures and cerebral cortical slices.

  2007cited by this paper
• Signaling cascades involved in neuroprotection by subpicomolar pituitary adenylate cyclase-activating polypeptide 38

  2007cited by this paper
• Effects of PACAP and VIP on cyclic AMP formation in rat neuronal and astrocyte cultures under normoxic and hypoxic condition.

  2007cited by this paper
• Neuroprotection: challenges and opportunities.

  2007cited by this paper
• Pituitary adenylate cyclase‐activating polypeptide is up‐regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage

  2007cited by this paper
• Retraction: Inhibition of Arachidonic Acid Release by Cytosolic Phospholipase A2 Is Involved in the Antiapoptotic Effect of FK506 and Cyclosporin A on Astrocytes Exposed to Simulated Ischemia In Vitro

  2006cited by this paper
• Neuroprotection by endogenous and exogenous PACAP following stroke.

  2006cited by this paper
• Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism.

  2006cited by this paper
• Inhibition of arachidonic acid release by cytosolic phospholipase A2 is involved in the antiapoptotic effect of FK506 and cyclosporin a on astrocytes exposed to simulated ischemia in vitro.

  2006cited by this paper
• Neuroprotective potential of three neuropeptides PACAP, VIP and PHI.

  2005cited by this paper
• Cobalt chloride, a hypoxia-mimicking agent, modulates redox status and functional parameters of cultured swine granulosa cells.

  2005cited by this paper
• A novel mechanism of FK506‐mediated neuroprotection: Downregulation of cytokine expression in glial cells

  2005cited by this paper
• Immunophilin ligands decrease release of pro-inflammatory cytokines (IL-1beta, TNF-alpha and IL-2 in rat astrocyte cultures exposed to simulated ischemia in vitro.

  2004cited by this paper
• Opposite regulation of the mitochondrial apoptotic pathway by C2‐ceramide and PACAP through a MAP‐kinase‐dependent mechanism in cerebellar granule cells

  2004cited by this paper
• Neuroprotective effects of an immunosuppressant agent on diffusion/perfusion mismatch in transient focal ischemia

  2004cited by this paper
• Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death

  2002cited by this paper
• The neuropeptide PACAP attenuates beta-amyloid (1-42)-induced toxicity in PC12 cells.

  2002cited by this paper
• PACAP protects neuronal PC12 cells from the cytotoxicity of human prion protein fragment 106–126

  2002cited by this paper
• Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP.

  2002cited by this paper
• Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia.

  2002cited by this paper
• PACAP protects cerebellar granule neurons against oxidative stress‐induced apoptosis

  2002cited by this paper
• The neuropeptide PACAP attenuates β-amyloid (1–42)-induced toxicity in PC12 cells

  2002cited by this paper
• BDNF mediates the neuroprotective effect of PACAP-38 on rat cortical neurons

  2001cited by this paper
• Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.

  2000cited by this paper
• Chemokines Released from Astroglia by Vasoactive Intestinal Peptide: Mechanism of Neuroprotection from HIV Envelope Protein Toxicity

  2000cited by this paper
• Hypoxic induction of vascular endothelial growth factor (VEGF) protein in astroglial cultures.

  1998cited by this paper
• Hypoxia‐induced vascular endothelial growth factor expression in normal rat astrocyte cultures

  1995cited by this paper
• Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction.

  1993cited by this paper
• A highly sensitive adenylate cyclase assay.

  1974cited by this paper
• A RADIOISOTOPIC METHOD FOR MEASURING THE FORMATION OF ADENOSINE 3′,5′‐CYCLIC MONOPHOSPHATE IN INCUBATED SLICES OF BRAIN

  1969cited by this paper

• Neuroprotective Effects of Cannabispirenone A against NMDA-Induced Excitotoxicity in Differentiated N2a Cells

  2024cites this paper
• The Potential Role of Gut Peptide Hormones in Autism Spectrum Disorder

  2020cites this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide: A Promising Neuroprotective Peptide in Stroke

  2020cites this paper
• Neurochemical characterization of the enteric neurons within the porcine jejunum in physiological conditions and under the influence of bisphenol A (BPA)

  2019cites this paper
• The Neuroprotective Effect of Forskolin and Its Influence of Mitochondrial Dysfunction in Neurons in Primary Rat Cerebellum Cultures

  2019cites this paper
• Inhibition of retinal ganglion cell apoptosis: regulation of mitochondrial function by PACAP

  2018cites this paper
• PACAP and PAC1R are differentially expressed in motor cortex of amyotrophic lateral sclerosis patients and support survival of iPSC‐derived motor neurons

  2018cites this paper
• Forskolin As a Neuroprotector and Modulator of Glutamate-Evoked Ca2+ Entry into Cerebellar Neurons

  2018cites this paper
• Involvement of vascular endothelial growth factor (VEGF) and mitogen-activated protein kinases (MAPK) in the mechanism of neuroleptic drugs

  2018cites this paper
• The differential effects of neuroleptic drugs and PACAP on the expression of BDNF mRNA and protein in a human glioblastoma cell line.

  2017cites this paper
• The effects of vasoactive intestinal peptide in neurodegenerative disorders

  2017cites this paper
• Role of transglutaminase 2 in PAC1 receptor mediated protection against hypoxia‐induced cell death and neurite outgrowth in differentiating N2a neuroblastoma cells

  2017cites this paper
• Pro-nociceptive migraine mediator CGRP provides neuroprotection of sensory, cortical and cerebellar neurons via multi-kinase signaling

  2017cites this paper
• Beta-adrenoceptor-mediated cyclic AMP signal in different types of cultured nerve cells in normoxic and hypoxic conditions

  2016cites this paper
• Role of PACAP in Astrocytes and Astrocytic Tumors

  2016cites this paper
• Multiple Actions of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Schwann Cell Biology

  2016cites this paper
• PACAP as a neuroprotective factor in ischemic neuronal injuries.

  2015cites this paper